Antimicrobial agents and chemotherapy

• 

  Año 2005, Vol. 49, Número 9

  • Association between the Pharmacokinetics and In Vivo Therapeutic Efficacy of Sulfadoxine-Pyrimethamine in Malawian Children

    F. K. Dzinjalamala

    págs. 3601-3606

    

  • Candidate Sulfonated and Sulfated Topical Microbicides: Comparison of Anti-Human Immunodeficiency Virus Activities and Mechanisms of Action

    I. A. Scordi-Bello

    págs. 3607-3615

    

  • Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

    N. Kartsonis

    págs. 3616-3623

    

  • Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

    V. H. Tam, A. N. Schilling

    págs. 3624-3630

    

  • Pharmacological Properties of a New Antimalarial Bisthiazolium Salt, T3, and a Corresponding Prodrug, TE3

    D. Margout, O. Nicolas

    págs. 3631-3639

    

  • Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

    V. J. Fraser, M. H. Kollef, M. Morrell

    págs. 3640-3645

    

  • Inactivation of Sterol Delta^5^,^6-Desaturase Attenuates Virulence in Candida albicans

    M. Laverdiere, M. Gurnani, R. Hawkinson, A. Cacciapuoti, A. S. Chau, P. M. McNicholas

    págs. 3646-3651

    

  • 2,4-Diaminopteridine-Based Compounds as Precursors for De Novo Synthesis of Antifolates: a Novel Class of Antimalarials

    E. Nduati

    págs. 3652-3657

    

  • Quinine Pharmacokinetics and Pharmacodynamics in Children with Malaria Caused by Plasmodium falciparum

    V. Jullien, E. Tetanye, M. Le Jouan

    págs. 3658-3662

    

  • Risk Factors for Acquisition of Multidrug-Resistant Pseudomonas aeruginosa Producing SPM Metallo-beta-Lactamase

    S. A. Nouer

    págs. 3663-3667

    

  • Effect of Recombinant Murine Granulocyte Colony-Stimulating Factor with or without Fluoroquinolone Therapy on Mixed-Infection Abscesses in Mice

    L. E. T. Stearne

    págs. 3668-3675

    

  • Absolute Bioavailability and Pharmacokinetics of Linezolid in Hospitalized Patients Given Enteral Feedings

    P. Beringer

    págs. 3676-3681

    

  • Purine Nucleobase Transport in Amastigotes of Leishmania mexicana: Involvement in Allopurinol Uptake

    M. I. Al-Salabi, H. P. de Koning

    págs. 3682-3689

    

  • Development of a Novel Targeting System for Lethal Photosensitization of Antibiotic-Resistant Strains of Staphylococcus aureus

    M. L. Embleton

    págs. 3690-3696

    

  • Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis

    D. M. MacCallum

    págs. 3697-3701

    

  • Pharmacokinetic Modeling of Free Amoxicillin Concentrations in Rat Muscle Extracellular Fluids Determined by Microdialysis

    S. Marchand

    págs. 3702-3706

    

  • Genomic Approach to Identifying the Putative Target of and Mechanisms of Resistance to Mefloquine in Mycobacteria

    L. Danelishvili

    págs. 3707-3714

    

  • In Vitro Efficacies of Nitazoxanide and Other Thiazolides against Neospora caninum Tachyzoites Reveal Antiparasitic Activity Independent of the Nitro Group

    S. L. Moores, M. Esposito, R. Stettler, C. Pidathala

    págs. 3715-3723

    

  • Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses in Vitro

    S. L. Williams Aziz

    págs. 3724-3733

    

  • Multidrug-Resistant Pseudomonas aeruginosa Strain That Caused an Outbreak in a Neurosurgery Ward and Its aac(6')-Iae Gene Cassette Encoding a Novel Aminoglycoside Acetyltransferase

    J. I Sekiguchi

    págs. 3734-3742

    

  • BEL-1, a Novel Clavulanic Acid-Inhibited Extended-Spectrum beta-Lactamase, and the Class 1 Integron In120 in Pseudomonas aeruginosa

    L. Poirel, Laura Briñas Herce, A. Verlinde, Louis Ide, Patrice Nordmann

    págs. 3743-3748

    

  • Short-Course Regimens of Artesunate-Fosmidomycin in Treatment of Uncomplicated Plasmodium falciparum Malaria

    S. Borrmann, A. A. Adegnika

    págs. 3749-3754

    

  • Design of a Small-Molecule Entry Inhibitor with Activity against Primary Measles Virus Strains

    R. K. Plemper

    págs. 3755-3761

    

  • Analysis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Subunit Structure/Function in the Context of Infectious Virions and Human Target Cells

    J. C. Kappes, A. Mulky

    págs. 3762-3769

    

  • Quantification of Different Human Alpha Interferon Subtypes and Pegylated Interferon Activities by Measuring MxA Promoter Activation

    I. Bernard, S. Castelain, C. Francois, B. Charleston

    págs. 3770-3775

    

  • Use of Leishmania donovani Field Isolates Expressing the Luciferase Reporter Gene in In Vitro Drug Screening

    S. Ramesh, S. Gupta

    págs. 3776-3783

    

  • Assessment of Effective Renal Plasma Flow, Enzymuria, and Cytokine Release in Healthy Volunteers Receiving a Single Dose of Amphotericin B Desoxycholate

    J. P. Norenberg, M. P. Pai

    págs. 3784-3788

    

  • Intensive Therapy with Ceftobiprole Medocaril of Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

    P. Vaudaux, A. Gjinovci

    págs. 3789-3793

    

  • Role of embB Codon 306 Mutations in Mycobacterium tuberculosis Revisited: a Novel Association with Broad Drug Resistance and IS6110 Clustering Rather than Ethambutol Resistance

    M. H. Hazbon, M. B. del Valle

    págs. 3794-3802

    

  • Mycobacterium smegmatis Erm(38) Is a Reluctant Dimethyltransferase

    S. Douthwaite, C. T. Madsen, L. Jakobsen

    págs. 3803-3809